TITLE

Access to medicines and global health: Will Canada lead or flounder?

PUB. DATE
January 2004
SOURCE
CMAJ: Canadian Medical Association Journal;1/20/2004, Vol. 170 Issue 2, p224
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on Bill C-56 and the efforts of Canada to address the suffering of people in the developing world who lack access to essential medicines. Estimated number of people living with HIV infection worldwide; Discussion on a second unanimous agreement on access to essential medicines on August 30, 2003 reached by WTO member governments; Provisions of Bill C-56.
ACCESSION #
11901928

 

Related Articles

  • Letters. Marshall, Tom; Gisselquist, David; Rothenberg, Richard; Potterat, John; Drucker, Ernest; Arya, Subhash C; Figueras, Albert; Laporte, Joan-Ramon; Greek, Ray; Pound, Pandora; Haigwood, Nancy L; Dwyer, Stuart W; Lawlor, D A; Ebrahim, S; Smith, G Davey; Pollard, Tessa M; Fischbacher, Colin; Unwin, Nigel; Ravnskov, Uffe // BMJ: British Medical Journal (International Edition);01/26/2002, Vol. 324 Issue 7331, p235 

    Presents letters to the editor on a number of medical topics as of January 26, 2002. View that doctors in Guantanamo Bay, Cuba at United States prison camps are at risk of being accessories to torture; Non-sexual transmission of HIV in developing countries; Need for adequate quality of HIV...

  • Driving a decade of change: HIV/AIDS, patents and access to medicines for all. Hoen, Ellen 't; Berger, Jonathan; Calmy, Alexandra; Moon, Suerie // Journal of the International AIDS Society;2011, Vol. 14 Issue 1, p1 

    Since 2000, access to antiretroviral drugs to treat HIV infection has dramatically increased to reach more than five million people in developing countries. Essential to this achievement was the dramatic reduction in antiretroviral prices, a result of global political mobilization that cleared...

  • Rates,barriers and outcomes of HIV serostatus disclosure among women in developing countries:implications for prevention of mother-to-child transmission programmes. Medley, Amy; Garcia-Moreno, Claudia; McGill, Scott; Maman, Suzanne // Bulletin of the World Health Organization;Apr2004, Vol. 82 Issue 4, p299 

    This paper synthesize stherates, barriers ,and outcomes of HIV serostatus disclosure among women in developing countries. We identified 17 studies from peer-reviewed journals and international conference abstracts -- 15 from sub-Saharan Africa and 2 from south-east Asia -- that included...

  • Mortality among patients with tuberculosis requiring intensive care: a retrospective cohort study. Silva, Denise R.; Menegotto, Diego M.; Schulz, Luis F.; Gazzana, Marcelo B.; Dalcin, Paulo T. R. // BMC Infectious Diseases;2010, Vol. 10 Issue 1, p54 

    Background: To describe the characteristics of patients with tuberculosis (TB) requiring intensive care and to identify the factors that predicts in-hospital mortality in a city of a developing country with intermediate-to-high TB endemicity. Methods: We conducted a retrospective, cohort study,...

  • The importance of doing HIV research in developing countries. Morris, Lynn; Martin, Desmond J.; Quinn, Thomas C.; Chaisson, Richard E. // Nature Medicine;Nov98, Vol. 4 Issue 11, p1228 

    Should scarce resources be spent on biomedical research into HIV/AIDS in countries that cannot afford anti-retroviral therapy for all their patients, or should all available resources be allocated to direct patient care rather than to research?

  • GA: Atlanta, GEORGIA.  // Advocate;4/28/87, Issue 471, p25 

    Reports on the failure to pass a legislation in Georgia that would require all blood samples drawn in the state to be tested for the HIV antibody. Refusal of Georgia senators to extend the legislative session long enough for the measure to be put up for a vote.

  • Approaches to the control of sexually transmitted infections in developing countries: old problems and modern challenges. Moyciud, P.; Mabey, D. // Sexually Transmitted Infections;Jun2004, Vol. 80 Issue 3, p174 

    Sexually transmitted infections (STIs) constitute a huge health and economic burden for developing countries: 75-85% of the estimated 340 million annual new cases of curable Sits occur in these countries, and STIs account for 17% economic losses because of ill health. The importance of Sits has...

  • The Medicines Patent Pool: improving access to ARVs and stimulating innovation for new medicines. Mara, Kaitlin // Africa Health;Jan2012, Vol. 34 Issue 2, p20 

    The article reports on the Medicines Patent Pool, a new mechanism aimed at improving the availability of quality, affordable, and HIV medicines in developing countries. It notes that many people on HIV treatment will build resistance to the drugs they have, and will need continued access to new...

  • Current medical treatment for tuberculosis. Chan, Edward D.; Iseman, Michael D. // BMJ: British Medical Journal (International Edition);11/30/2002, Vol. 325 Issue 7375, p1282 

    Discusses how instigating effective treatment regiments in a way that improves patient adherence is vital to stopping the global resurgence of tuberculosis. Chemotherapy and multidrug regimen; Number of cases of tuberculosis worldwide; Causes of tuberculosis; Drug testing; Multidrug resistant...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics